JACQUELINE GRAZIANI: Open Payments
NPI 1861823676 · LORAIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,392 in 65 payments from 22 companies in 2025. Trend: 2023 $4,427 · 2024 $1,673 · 2025 $1,392
Food & beverage: $1,092Consulting: $300
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $397 |
| Biogen, Inc. | 2 | $174 |
| JAZZ PHARMACEUTICALS INC. | 1 | $150 |
| UCB, Inc. | 3 | $78 |
| EMD Serono, Inc. | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Celgene Corporation | 4 | $68 |
| Genentech USA, Inc. | 2 | $55 |
| Lundbeck LLC | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
Products named: QULIPTA, TYSABRI, UBRELVY, XYWAV, KESIMPTA, ZEPOSIA, Ocrevus Zunovo, Zilbrysq.
Industry payments across OH — which companies pay providers there.
